Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

AltheaDx Receives CLIA Certification
AltheaDx, a world leader in the development of companion diagnostics and biopharma services, announced that they have successfully passed the State of California survey for CLIA (Clinical Laboratory Improvement Amendments) certification. AltheaDx is offering high-quality patient and biopharma molecular testing services from their state-of-the-art, GMP, GLP, and now CLIA compliant facility located in the Sorrento Valley, San Diego.
generic viagra online
Yale Team Identifies Key To Potential New Treatment For Allergy-Induced Asthma
In research that could lead to new asthma drugs, scientists at Yale School of Medicine, Hydra Biosciences of Cambridge, Massachusetts, and the University of California, San Francisco have discovered that a protein may be a trigger of allergy-induced asthma in mice. They also demonstrated how a drug known to reduce inflammatory and neuropathic pain may also inhibit asthma symptoms in mice. Their paper is published in the May 18-22 online Early Edition of the Proceedings of the National Academy of Sciences.
News of the day
Sylvester Breast Cancer Researchers Win Prestigious Department Of Defense Grant To Expand Study Of African-American Women
Breast cancer researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have been awarded a prestigious Department of Defense Synergistic Idea Award, one of just 12 such grants in the United States. The $725,000 research grant over two years will allow Lisa Baumbach, Ph.D., associate professor of pediatrics at the Miller School, and Mark Pegram, M.D., professor of medicine and associate director for clinical and translational research at the Braman Family Breast Cancer Institute at Sylvester, to expand their work examining the genetic differences found in African-American breast cancer patients.
Endocrinology

Launch Of Fund To Advance Scientific Discoveries Into Clinical Practice, UK

The Department of Health and the Wellcome Trust invited proposals from organisations and research groups seeking to draw on funding from the Health Innovation Challenge Fund to further the development of innovative healthcare products The aim of the Health Innovation Challenge Fund is to facilitate high-quality translational health research - technological developments that can deliver economic and patient health benefits to this country and build on the UK"s excellence in science. Through the provision of "gap-bridging" funding, the initiative will stimulate the delivery of technologies, products and interventions having clinical applicability within the NHS in the 3 - 5 year timeframe. A series of themed calls will be made, the first of which is "Advancing Genetic Discoveries into Clinical Practice" with funding up to ÷£20m. This seeks to capitalize on the wealth of information created by human genome analysis and the drivers to bring the emerging insights to clinical application. Health Minister Lord Darzi said: "We must support innovation in order to respond to the challenges we face - especially where res are constrained. New ideas need to be tested, to ensure they are successful and add value - and this requires investment. There is a significant body of evidence to suggest that investment in innovation produces long-term benefits overall. The Healthcare Innovation Challenge Fund will provide vital re and support to the UK healthcare sector." Sir Mark Walport, Director of the Welcome Trust, said: "The Wellcome Trust is a committed funder of translational research. Our partnership with the Department of Health should provide a valuable catalyst to stimulate the research community to apply their ideas and emerging technologies to patient care. The call for proposals in medical genetics is timely and important, given the tremendous pace of developments arising from the application of genome sequencing to improved understanding of human variation in health and disease. This scheme fits well with the recent recommendations of the House of Lords Select Committee report on Genomic Medicine." The Health Innovation Challenge Fund forms part of Lord Darzi"s strategy for the future of the NHS - High Quality Care for All - in which he committed to creating a pioneering NHS where innovation can flourish. Today"s announcement reinforces the Government"s commitment to supporting the UK life sciences and biotechnology sector and complements the Wellcome Trust"s aim of improving health through research and its timely application to product development for the benefit of patients and society. The Health Innovation Challenge Fund is a scheme of up to five years supported by up to ÷£100 million contributed in equal measure by the Department of Health and the Wellcome Trust, the biggest medical research charity in the UK. Department of Health, UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009